These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 20823296)
21. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers. Mita Y; Yasuda Y; Sakai A; Yamamoto H; Toyooka S; Gunduz M; Tanabe S; Naomoto Y; Ouchida M; Shimizu K J Cancer Res Clin Oncol; 2010 Feb; 136(2):249-59. PubMed ID: 19672627 [TBL] [Abstract][Full Text] [Related]
22. Genetic and Epigenetic Association of Achilla C; Chorti A; Papavramidis T; Angelis L; Chatzikyriakidou A Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000267 [TBL] [Abstract][Full Text] [Related]
24. The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients. Ozgen AG; Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C J Endocrinol Invest; 2009 Jun; 32(6):491-4. PubMed ID: 19494710 [TBL] [Abstract][Full Text] [Related]
25. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas. Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717 [TBL] [Abstract][Full Text] [Related]
26. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population. Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075 [TBL] [Abstract][Full Text] [Related]
27. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation. Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688 [TBL] [Abstract][Full Text] [Related]
28. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma. Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375 [TBL] [Abstract][Full Text] [Related]
29. The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population. Wang YX; Li ML; Yu SG; Liu CM; Han Y; Wang XY Pathol Res Pract; 2013 Mar; 209(3):151-4. PubMed ID: 23414714 [TBL] [Abstract][Full Text] [Related]
30. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483 [TBL] [Abstract][Full Text] [Related]
31. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma]. Zhu QX; Bian JC; Shen Q; Jiang F; Tang HW; Zhang HW; Wu Y Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):702-5. PubMed ID: 15555397 [TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis between trefoil factor 3 gene polymorphsims and susceptibility to papillary thyroid carcinoma]. Pei D; Xue G; Wu JF; Wang DM; Qin XJ Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):926-931. PubMed ID: 31623036 [No Abstract] [Full Text] [Related]
33. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters. Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578 [TBL] [Abstract][Full Text] [Related]
34. Correlation between Zhang F; Fan G; Wang X Biomark Med; 2022 May; 16(7):537-547. PubMed ID: 35362324 [No Abstract] [Full Text] [Related]
35. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843 [TBL] [Abstract][Full Text] [Related]
36. Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population. Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ertan Y; Uluer H; Yilmaz C; Tuzun M; Kabalak T; Ozgen AG J Endocrinol Invest; 2007 May; 30(5):411-6. PubMed ID: 17598974 [TBL] [Abstract][Full Text] [Related]
37. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma. Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194 [TBL] [Abstract][Full Text] [Related]
38. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer. Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721 [TBL] [Abstract][Full Text] [Related]
39. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer. Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759 [TBL] [Abstract][Full Text] [Related]
40. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer. Eun YG; Kim SK; Chung JH; Kwon KH Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]